Yusuf Dolen

Yusuf Dolen

Auto-generated profile, based on publicly available information

Yusuf Dolen

Department of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2011 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
YCYusuf Cakmak
Yusuf Cakmak
SKSafacan Kolemen
Safacan Kolemen
SDSelin Duman
Selin Duman
YDYavuz Dede
Yavuz Dede
YDYusuf Dolen
Yusuf Dolen
EAEngin Umut Akkaya
Engin Umut Akkaya

28 July 2015 in OncoImmunology
Verified
Journal Article
Open access
YDYusuf Dölen
Yusuf Dölen
MKMartin Kreutz
Martin Kreutz
UGUzi Gileadi
Uzi Gileadi
JTJurjen Tel
Jurjen Tel
AVAngela Vasaturo
Angela Vasaturo
CFCarl Figdor
Carl Figdor
Antitumor immunity can be enhanced by the coordinated release and delivery of antigens and immune-stimulating agents to antigen-presenting cells via biodegradable vaccine carriers. So far, encapsulation of TLR ligands and tumor-associated antigens augmented cytotoxic T cell (CTLs) responses. Here, we compared the efficacy of the invariant NKT (iNKT) cell agonist α-galactosylceramide (α-GalCer) and TLR ligands (R848 and poly I:C) as an adjuvant for the full length ovalbumin (OVA) in PLGA nanoparticles. We observed that OVA+α-GalCer nanoparticles (NP) are superior over OVA+TLR-L NP in generating and stimulating antigen-specific cytotoxic T lymphocytes without the need for CD4+ T cell help. Not only a 4-fold higher induction of antigen-specific T cells was observed, but also a more profound IFN-γ secretion was obtained by the addition α-GalCer. Surprisingly, we observed that mixtures of OVA containing NP with α-GalCer were ineffective, demonstrating that co-encapsulation of both α-GalCer and antigen within the same nanoparticle is essential for the observed T cell responses. Moreover, a single immunization with OVA+α-GalCer NP provided substantial protection from tumor formation and even delayed the growth of already established tumors, which coincided with a prominent and enhanced antigen-specific CD8+ T cell infiltration. The provided evidence on the advantage of antigen and α-GalCer coencapsulation should be considered in the design of future nanoparticle vaccines for therapeutic purposes.

20 October 2011 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
YCYusuf Cakmak
Yusuf Cakmak
SKSafacan Kolemen
Safacan Kolemen
SDSelin Duman
Selin Duman
YDYavuz Dede
Yavuz Dede
YDYusuf Dolen
Yusuf Dolen
EAEngin U. Akkaya
Engin U. Akkaya

23 November 2012 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
YDYusuf Dolen
Yusuf Dolen
GEGunes Esendagli
Gunes Esendagli
Expression of the B7 family molecules in acute myeloid leukemia (AML) has been demonstrated by independent clinical studies. Intriguingly, the expression of the most potent costimulatory molecules B7‐2 (CD86) and B7‐H2 (ICOS Ligand) on AML cells has been associated with poor prognosis and disease severity. Here, this phenomenon was modeled in vitro with the myeloid leukemia cell line HL‐60, which is capable of differentiating through the FAB M2/M3 and M4/M5 immunophenotypes. These derivatives of HL‐60 harbored a B7‐2+ subpopulation and recapitulated the distribution of B7 ligands previously reported in primary AML cases. B7‐2+ AML cells significantly contributed to T‐cell responses. This costimulatory activity enabled helper (Th)‐cell activation, proliferation, and production of Th1‐associated cytokines. Conversely, even a short‐term incubation with stimulated T cells resulted in upregulation of inhibitory B7‐H1 (PD‐L1) and B7‐DC (PD‐L2), and downregulation of stimulatory B7‐H2 molecules on leukemia cells. Purified from iHL‐60‐T‐cell co‐cultures, these myeloid leukemia cells severely suppressed Th‐cell responses specifically through the PD‐1 pathway. In conclusion, Th‐cell responses can be directly supported by B7‐2+ leukemia subpopulations. However, this interaction can facilitate the acquisition of a suppressive character that may contribute to immune evasion in myeloid leukemia.

1 March 2018 in Small
Verified
Journal Article
Closed access
PDF file
LQLiping Qiu
Liping Qiu
MVMichael Valente
Michael Valente
YDYusuf Dolen
Yusuf Dolen
EJEliezer Jäger
Eliezer Jäger
MBMartin ter Beest
Martin ter Beest
MVMartijn Verdoes
Martijn Verdoes

3 December 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MVM. Valente
M. Valente
YDY. Dölen
Y. Dölen
EDE. van Dinther
E. van Dinther
LVL. Vimeux
L. Vimeux
MFM. Fallet
M. Fallet
CFCarl Figdor
Carl Figdor
Mounting an effective immune response relies critically on the coordinated interactions between adaptive and innate compartments. How and where immune cells from these different compartments interact is still poorly understood. Here, we demonstrate that the cross-talk between invariant natural killer T cells (iNKT) and CD8 + T cells in the spleen, essential for initiating productive immune responses, is biphasic and occurs at 2 distinct sites. Codelivery of antigen and adjuvant to antigen-presenting cells results in: 1) initial short-lived interactions (0 to 6 h), between CD8 + T cells, dendritic cells (DCs), and iNKT cells recruited outside the white pulp; 2) followed by long-lasting contacts (12 to 24 h) between iNKT cells, DCs, and CD8 + T cells occurring in a 3-way interaction profile within the white pulp. Both CXCR3 and CCR4 are essential to orchestrate this highly dynamic process and play nonredundant in T cell memory generation. While CXCR3 promotes memory T cells, CCR4 supports short-lived effector cell generation. We believe our work provides insights into the initiation of T cell responses in the spleen and their consequences for T cell differentiation.